4.6 Article

Liver damage during organ donor procurement in donation after circulatory death compared with donation after brain death

Journal

BRITISH JOURNAL OF SURGERY
Volume 100, Issue 3, Pages 381-386

Publisher

WILEY-BLACKWELL
DOI: 10.1002/bjs.9009

Keywords

-

Categories

Ask authors/readers for more resources

Background: During the past decade the number of livers recovered and transplanted from donation after circulatory death (DCD) donors has increased significantly. As reported previously, injuries are more frequent during kidney procurement from DCD than from donation after brain death (DBD) donors. This aim of this study was to compare outcomes between DCD and DBD with respect to liver injuries. Methods: Data on liver injuries in organs procured between 2000 and 2010 were obtained from the UK Transplant Registry. Results: A total of 7146 livers were recovered from deceased donors during the study, 628 (8.8 per cent) from DCD donors. Injuries occurred in 1001 procedures (14.0 per cent). There were more arterial (1.6 versus 1.0 per cent), portal (0.5 versus 0.3 per cent) and caval (0.3 versus 0.2 per cent) injuries in the DBD group than in the DCD group, although none of these findings was statistically significant. Capsular injuries occurred more frequently in DCD than DBD (15.6 versus 11.4 per cent; P = 0.002). There was no significant difference between DCD and DBD groups in liver discard rates related to damage. Conclusion: There were no differences in terms of vascular injuries between DCD and DBD livers, although capsular injuries occurred more frequently in DCD organs. Continuing the trend for increased frequency of DCD liver recovery, and ensuring that there is an adequately skilled surgical team available for procurement, is vital to improving the utilization of DCD livers. Copyright (c) 2012 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

Severity of Severe Acute Respiratory System Coronavirus 2 (SARS-CoV-2) Alpha Variant (B.1.1.7) in England

Daniel J. Grint, Kevin Wing, Catherine Houlihan, Hamish P. Gibbs, Stephen J. W. Evans, Elizabeth Williamson, Helen McDonald, Krishnan Bhaskaran, David Evans, Alex J. Walker, George Hickman, Emily Nightingale, Anna Schultze, Christopher T. Rentsch, Chris Bates, Jonathan Cockburn, Helen J. Curtis, Caroline E. Morton, Sebastian Bacon, Simon Davy, Angel Y. S. Wong, Amir Mehrkar, Laurie Tomlinson, Ian J. Douglas, Rohini Mathur, Brian MacKenna, Peter Ingelsby, Richard Croker, John Parry, Frank Hester, Sam Harper, Nicholas J. DeVito, Will Hulme, John Tazare, Liam Smeeth, Ben Goldacre, Rosalind M. Eggo

Summary: The study found that the SARS-CoV-2 alpha variant is more transmissible and associated with increased rates of hospitalization and mortality compared to the wild-type virus in England between November 16, 2020 and January 11, 2021.

CLINICAL INFECTIOUS DISEASES (2022)

Article Primary Health Care

Association between oral anticoagulants and COVID-19-related outcomes: a population-based cohort study

Angel Y. S. Wong, Laurie Tomlinson, Jeremy P. Brown, William Elson, Alex J. Walker, Anna Schultze, Caroline E. Morton, David Evans, Peter Inglesby, Brian MacKenna, Krishnan Bhaskaran, Christopher Rentsch, Emma Powell, Elizabeth Williamson, Richard Croker, Seb Bacon, William Hulme, Chris Bates, Helen J. Curtis, Amir Mehrkar, Jonathan Cockburn, Helen McDonald, Rohini Mathur, Kevin Wing, Harriet Forbes, Rosalind M. Eggo, Stephen J. W. Evans, Liam Smeeth, Ben Goldacre, Ian J. Douglas

Summary: This study investigated the association between routinely prescribed oral anticoagulants (OACs) and COVID-19 outcomes in patients with atrial fibrillation. The results showed that individuals receiving OACs had a lower risk of COVID-19 infection and severe outcomes compared to non-users.

BRITISH JOURNAL OF GENERAL PRACTICE (2022)

Article Primary Health Care

OpenSAFELY NHS Service Restoration Observatory 1: primary care clinical activity in England during the first wave of COVID-19

Helen J. Curtis, Brian MacKenna, Richard Croker, Peter Inglesby, Alex J. Walker, Jessica Morley, Amir Mehrkar, Caroline E. Morton, Seb Bacon, George Hickman, Chris Bates, David Evans, Tom Ward, Jonathan Cockburn, Simon Davy, Krishnan Bhaskaran, Anna Schultze, Christopher T. Rentsch, Elizabeth J. Williamson, William J. Hulme, Helen McDonald, Laurie Tomlinson, Rohini Mathur, Henry Drysdale, Rosalind M. Eggo, Kevin Wing, Angel Y. S. Wong, Harriet Forbes, John Parry, Frank Hester, Sam Harper, Stephen J. W. Evans, Ian J. Douglas, Liam Smeeth, Ben Goldacre

Summary: The study found that the COVID-19 pandemic led to a decrease in coded clinical activity in general practice, but most activities had largely recovered by September. Laboratory tests saw a significant drop but recovered to near-normal levels, with respiratory symptoms less affected and respiratory infections remaining below pre-pandemic levels by September.

BRITISH JOURNAL OF GENERAL PRACTICE (2022)

Article Multidisciplinary Sciences

Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records

Ellen J. Thompson, Dylan M. Williams, Alex J. Walker, Ruth E. Mitchell, Claire L. Niedzwiedz, Tiffany C. Yang, Charlotte F. Huggins, Alex S. F. Kwong, Richard J. Silverwood, Giorgio Di Gessa, Ruth C. E. Bowyer, Kate Northstone, Bo Hou, Michael J. Green, Brian Dodgeon, Katie J. Doores, Emma L. Duncan, Frances M. K. Williams, Andrew Steptoe, David J. Porteous, Rosemary R. C. McEachan, Laurie Tomlinson, Ben Goldacre, Praveetha Patalay, George B. Ploubidis, Srinivasa Vittal Katikireddi, Kate Tilling, Christopher T. Rentsch, Nicholas J. Timpson, Nishi Chaturvedi, Claire J. Steves, Alex J. Walker, Brian MacKenna, Peter Inglesby, Helen J. Curtis, Caroline E. Morton, Jessica Morley, Amir Mehrkar, Seb Bacon, George Hickman, Chris Bates, Richard Croker, David Evans, Tom Ward, Jonathan Cockburn, Simon Davy, Krishnan Bhaskaran, Anna Schultze, Elizabeth J. Williamson, William J. Hulme, Simon Davy, Helen McDonald, Rohini Mathur, Rosalind M. Eggo, Kevin Wing, Angel Y. S. Wong, Harriet Forbes, John Tazare, John Parry, Frank Hester, Sam Harper, Ian J. Douglas, Stephen J. W. Evans, Liam Smeeth

Summary: The frequency and risk factors of long COVID in community-based individuals are unclear. A study analyzing data from 10 UK population-based studies and electronic health records found wide variation in the frequency of long COVID between studies, but identified some consistent risk factors.

NATURE COMMUNICATIONS (2022)

Article Medicine, General & Internal

Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY

William J. Hulme, Elizabeth J. Williamson, Amelia C. A. Green, Krishnan Bhaskaran, Helen McDonald, Christopher T. Rentsch, Anna Schultze, John Tazare, Helen J. Curtis, Alex J. Walker, Laurie A. Tomlinson, Tom Palmer, Elsie M. F. Horne, Brian MacKenna, Caroline E. Morton, Amir Mehrkar, Jessica Morley, Louis Fisher, Sebastian C. J. Bacon, David Evans, Peter Inglesby, George Hickman, Simon Davy, Tom Ward, Richard Croker, Rosalind M. Eggo, Angel Y. S. Wong, Rohini Mathur, Kevin Wing, Harriet Forbes, Daniel J. Grint, Ian J. Douglas, Stephen J. W. Evans, Liam Smeeth, Chris Bates, Jonathan Cockburn, John Parry, Frank Hester, Sam Harper, Jonathan A. C. Sterne, Miguel A. Hernan, Ben Goldacre

Summary: This study compared the effectiveness of the BNT162b2 mRNA (Pfizer-BioNTech) and the ChAdOx1 (Oxford-AstraZeneca) covid-19 vaccines in health and social care workers. The results showed no substantial differences in the incidence of SARS-CoV-2 infection or covid-19 disease up to 20 weeks after vaccination. Incidence dropped sharply at 3-4 weeks after vaccination.

BMJ-BRITISH MEDICAL JOURNAL (2022)

Article Medicine, General & Internal

Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records

Elsie M. F. Horne, William J. Hulme, Ruth H. Keogh, Tom M. Palmer, Elizabeth J. Williamson, Edward P. K. Parker, Amelia Green, Venexia Walker, Alex J. Walker, Helen Curtis, Louis Fisher, Brian MacKenna, Richard Croker, Lisa Hopcroft, Robin Y. Park, Jon Massey, Jessica Morley, Amir Mehrkar, Sebastian Bacon, David Evans, Peter Inglesby, Caroline E. Morton, George Hickman, Simon Davy, Tom Ward, Iain Dillingham, Ben Goldacre, Miguel A. Hernan, Jonathan A. C. Sterne

Summary: This study aimed to evaluate the waning of COVID-19 vaccine effectiveness after the second dose over a period of six months. The findings showed similar trends of declining vaccine effectiveness for both BNT162b2 and ChAdOx1 vaccines, and across different age and clinical vulnerability subgroups. Despite the waning effectiveness, rates of COVID-19-related hospital admission and death remained significantly lower among vaccinated individuals compared to unvaccinated individuals up to 26 weeks after the second dose. The estimated vaccine effectiveness was above 80% for BNT162b2 and above 75% for ChAdOx1. However, in the 23-26 week period, rates of positive SARS-CoV-2 tests in vaccinated individuals were similar to or higher than those in unvaccinated individuals.

BMJ-BRITISH MEDICAL JOURNAL (2022)

Article Rheumatology

Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform

Brian MacKenna, Nicholas A. Kennedy, Amir Mehrkar, Anna Rowan, James Galloway, Julian Matthewman, Kathryn E. Mansfield, Katie Bechman, Mark Yates, Jeremy Brown, Anna Schultze, Sam Norton, Alex J. Walker, Caroline E. Morton, David Harrison, Krishnan Bhaskaran, Christopher T. Rentsch, Elizabeth Williamson, Richard Croker, Seb Bacon, George Hickman, Tom Ward, Simon Davy, Amelia Green, Louis Fisher, William Hulme, Chris Bates, Helen J. Curtis, John Tazare, Rosalind M. Eggo, David Evans, Peter Inglesby, Jonathan Cockburn, Helen McDonald, Laurie A. Tomlinson, Rohini Mathur, Angel Y. S. Wong, Harriet Forbes, John Parry, Frank Hester, Sam Harper, Ian J. Douglas, Liam Smeeth, Charlie W. Lees, Stephen J. W. Evans, Ben Goldacre, Catherine H. Smith, Sinead M. Langan

Summary: This study aimed to assess the risk of severe COVID-19 outcomes in adults with immune-mediated inflammatory diseases and on immune-modifying therapies. The findings showed that adults with immune-mediated inflammatory diseases had an increased risk of COVID-19-related death, critical care admission or death, and hospital admission compared to the general population, but most targeted immune-modifying drugs did not increase the risk of adverse COVID-19 outcomes.

LANCET RHEUMATOLOGY (2022)

Article Primary Health Care

OpenSAFELY NHS Service Restoration Observatory 2: changes in primary care clinical activity in England during the COVID-19 pandemic

Helen J. Curtis, Brian MacKenna, Milan Wiedemann, Louis Fisher, Richard Croker, Caroline E. Morton, Peter Inglesby, Alex J. Walker, Jessica Morley, Amir Mehrkar, Sebastian C. J. Bacon, George Hickman, David Evans, Tom Ward, Simon Davy, William J. Hulme, Orla Macdonald, Robin Conibere, Tom Lewis, Martin Myers, Shamila Wanninayake, Kiren Collison, Charles Drury, Miriam Samuel, Harpreet Sood, Andrea Cipriani, Seena Fazel, Manuj Sharma, Wasim Baqir, Chris Bates, John Parry, Ben Goldacre

Summary: The COVID-19 pandemic has caused significant disruptions to healthcare activities, with the NHS stopping non-urgent work and later recommending a near-normal level of service before winter. A study found substantial and widespread changes in clinical activity in general practice, although there was good recovery by December 2020. The study suggests that population-scale NHS general practice data can be used to monitor disruptions and guide mitigation strategies.

BRITISH JOURNAL OF GENERAL PRACTICE (2023)

Article Medicine, General & Internal

Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study

Edward P. K. Parker, John Tazare, William J. Hulme, Christopher Bates, Edward J. Carr, Jonathan Cockburn, Helen J. Curtis, Louis Fisher, Amelia C. A. Green, Sam Harper, Frank Hester, Elsie M. F. Horne, Fiona Loud, Susan Lyon, Viyaasan Mahalingasivam, Amir Mehrkar, Linda Nab, John Parry, Shalini Santhakumaran, Retha Steenkamp, Jonathan A. C. Sterne, Alex J. Walker, Elizabeth J. Williamson, Michelle Willicombe, Bang Zheng, Ben Goldacre, Dorothea Nitsch, Laurie A. Tomlinson

Summary: This retrospective cohort study aimed to identify factors associated with COVID-19 vaccine uptake among people with kidney disease in England. The study found that although most individuals received the COVID-19 vaccine, there were disparities in vaccine uptake among different clinical and demographic groups, and the coverage of complete vaccine doses was suboptimal.

BMJ OPEN (2023)

Article Medicine, General & Internal

Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform

Bang Zheng, Amelia C. A. Green, John Tazare, Helen J. Curtis, Louis Fisher, Linda Nab, Anna Schultze, Viyaasan Mahalingasivam, Edward P. K. Parker, William J. Hulme, Sebastian C. J. Bacon, Nicholas J. DeVito, Christopher Bates, David Evans, Peter Inglesby, Henry Drysdale, Simon Davy, Jonathan Cockburn, Caroline E. Morton, George Hickman, Tom Ward, Rebecca M. Smith, John Parry, Frank Hester, Sam Harper, Amir Mehrkar, Rosalind M. Eggo, Alex J. Walker, Stephen J. W. Evans, Ian J. Douglas, Brian MacKenna, Ben Goldacre, Laurie A. Tomlinson

Summary: This study compared the effectiveness of sotrovimab and molnupiravir in preventing severe outcomes of covid-19 in high-risk patients. The results showed that treatment with sotrovimab was associated with a significantly lower risk of severe outcomes compared to treatment with molnupiravir.

BMJ-BRITISH MEDICAL JOURNAL (2022)

Article Medicine, General & Internal

Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational Data

William J. Hulme, Elizabeth Williamson, Elsie M. F. Horne, Amelia Green, Helen I. I. McDonald, Alex J. J. Walker, Helen J. J. Curtis, Caroline E. Morton, Brian MacKenna, Richard Croker, Amir Mehrkar, Seb Bacon, David Evans, Peter Inglesby, Simon Davy, Krishnan Bhaskaran, Anna Schultze, Christopher T. Rentsch, Laurie Tomlinson, Ian J. Douglas, Stephen J. W. Evans, Liam Smeeth, Tom Palmer, Ben Goldacre, Miguel A. Hernan, Jonathan A. C. Sterne

Summary: The COVID-19 vaccines were developed and evaluated through randomized trials, but important questions remain unanswered. Observational studies and target trial emulation can provide valuable insights, although potential biases need to be managed. This article presents two approaches to emulate target trials using observational data.

ANNALS OF INTERNAL MEDICINE (2023)

Article Medicine, General & Internal

Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPP

William J. Hulme, Elsie M. F. Horne, Edward P. K. Parker, Ruth H. Keogh, Elizabeth J. Williamson, Venexia Walker, Tom M. Palmer, Helen J. Curtis, Alex J. Walker, Colm D. Andrews, Amir Mehrkar, Jessica Morley, Brian MacKenna, Sebastian C. J. Bacon, Ben Goldacre, Miguel A. Hernan, Jonathan A. C. Sterne

Summary: A study compared the effectiveness of the BNT162b2 mRNA (Pfizer-BioNTech) and mRNA-1273 (Moderna) covid-19 vaccines during the booster programme in England. The results showed that mRNA-1273 had a modest benefit in preventing positive SARS-CoV-2 tests and hospital admission with covid-19 compared to BNT162b2.

BMJ-BRITISH MEDICAL JOURNAL (2023)

Article Biology

Eleven key measures for monitoring general practice clinical activity during COVID-19: A retrospective cohort study using 48 million adults' primary care records in England through OpenSAFELY

Louis Fisher, Helen J. Curtis, Richard Croker, Milan Wiedemann, Victoria Speed, Christopher Wood, Andrew Brown, Lisa E. M. Hopcroft, Rose Higgins, Jon Massey, Peter Inglesby, Caroline E. Morton, Alex J. Walker, Jessica Morley, Amir Mehrkar, Seb Bacon, George Hickman, Orla Macdonald, Tom Lewis, Marion Wood, Martin Myers, Miriam Samuel, Robin Conibere, Wasim Baqir, Harpreet Sood, Charles Drury, Kiren Collison, Chris Bates, David Evans, Iain Dillingham, Tom Ward, Simon Davy, Rebecca M. Smith, William Hulme, Amelia Green, John Parry, Frank Hester, Sam Harper, Jonathan Cockburn, Shaun O'Hanlon, Alex Eavis, Richard Jarvis, Dima Avramov, Paul Griffiths, Aaron Fowles, Nasreen Parkes, Brian MacKenna, Ben Goldacre, Talia Malagon

Summary: The OpenSAFELY Service Restoration Observatory (SRO) was developed to monitor and describe the trends in primary care activity during the COVID-19 pandemic. The study found a significant drop in activity across all measures at the beginning of the pandemic. By April 2021, six measures had recovered to within 15% of the activity levels in April 2019, while the remaining measures continued to show a sustained drop, with three measures still decreasing by December 2021.

ELIFE (2023)

Article Biology

Healthcare in England was affected by the COVID-19 pandemic across the pancreatic cancer pathway: A cohort study using OpenSAFELY-TPP

Agnieszka Lemanska, Colm Andrews, Louis Fisher, Seb Bacon, Adam E. Frampton, Amir Mehrkar, Peter Inglesby, Simon Davy, Keith Roberts, Praveetha Patalay, Ben Goldacre, Brian MacKenna, Alex J. Walker, OpenSAFELY Collaborative

Summary: Healthcare services for pancreatic cancer patients in the UK were negatively affected by the COVID-19 pandemic, with a decrease in surgical resections and fewer diagnostic tests conducted. However, there was no significant impact on primary care visits, emergency department visits, hospital admissions, and deaths. These findings highlight the challenges in providing adequate healthcare for pancreatic cancer patients during a pandemic.

ELIFE (2023)

Article Public, Environmental & Occupational Health

Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform

Linda Nab, Edward P. K. Parker, Colm D. Andrews, William J. Hulme, Louis Fisher, Jessica Morley, Amir Mehrkar, Brian MacKenna, Peter Inglesby, Caroline E. Morton, Sebastian C. J. Bacon, George Hickman, David Evans, Tom Ward, Rebecca M. Smith, Simon Davy, Iain Dillingham, Steven Maude, Ben F. C. Butler-Cole, Thomas O'Dwyer, Catherine L. Stables, Lucy Bridges, Christopher Bates, Jonathan Cockburn, John Parry, Frank Hester, Sam Harper, Bang Zheng, Elizabeth J. Williamson, Rosalind M. Eggo, Stephen J. W. Evans, Ben Goldacre, Laurie A. Tomlinson, Alex J. Walker

Summary: This study examined trends in COVID-19-related mortality risks among different demographic and clinical population subgroups during successive waves of the pandemic. The findings showed a decrease in absolute COVID-19-related death rates over time in the overall population, but the relative risk profiles for vulnerable subgroups with lower vaccination coverage or impaired immune response persisted and worsened.

LANCET PUBLIC HEALTH (2023)

No Data Available